INDUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST (IL-1RA) FOLLOWING SURGERY IS ASSOCIATED WITH MAJOR TRAUMA

被引:24
作者
NUALLAIN, EMO [1 ]
PURI, P [1 ]
MEALY, K [1 ]
REEN, DJ [1 ]
机构
[1] ST JAMES HOSP,DEPT SURG,DUBLIN 8,IRELAND
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1995年 / 76卷 / 01期
关键词
D O I
10.1006/clin.1995.1093
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Injury and trauma are major inducers of the acute-phase response. Among the major cytokine mediators of this response is interleukin-6, which is considered to be an early indicator of tissue damage following trauma. We have previously reported, in a group of children undergoing a single abdominal surgical procedure, the early induction of interleukin-1 receptor antagonist following the commencement of surgery. In the present study, we investigated the production of cytokines IL-1ra, IL-1 beta, and IL-6 in patients undergoing a range of surgical procedures to examine whether IL-1ra release is a general phenomenon or is restricted to certain categories of surgery. Peripheral blood mononuclear cells and polymorphonuclear leukocytes from patients were studied as a possible source of induced IL-1ra, IL-1ra and IL-6 were induced in 44 and 53 of the 73 patients, respectively. Induction of these cytokines was associated with major operative procedures of the abdomen and thorax and in hip replacement. Levels of these two cytokines varied widely within the different surgical categories. IL-1ra reached maximum levels before IL-6 in 18 patients and at the same time in 20 patients. IL-1 beta levels were induced in only 6 patients. Endotoxin levels were not detected in association with induction of IL-1ra. IL-1ra was not upregulated in peripheral blood mononuclear cells or polymorphonuclear leukocytes obtained from patients following surgery suggesting that these cells are not the source of plasma IL-1ra induced following trauma. These results provide new insights into the regulation of IL-1ra in vivo in humans. They show that IL-1ra can be induced as an early-response cytokine following major trauma in the absence of an infectious etiology. (C) 1995 Academic Press,Inc.
引用
收藏
页码:96 / 101
页数:6
相关论文
共 25 条
[1]  
AREND WP, 1991, J IMMUNOL, V147, P1530
[2]   INTERLEUKIN-10 (IL-10) UP-REGULATES IL-1 RECEPTOR ANTAGONIST PRODUCTION FROM LIPOPOLYSACCHARIDE-STIMULATED HUMAN POLYMORPHONUCLEAR LEUKOCYTES BY DELAYING MESSENGER-RNA DEGRADATION [J].
CASSATELLA, MA ;
MEDA, L ;
GASPERINI, S ;
CALZETTI, F ;
BONORA, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1695-1699
[3]   MODALITIES FOR REDUCING INTERLEUKIN-1 ACTIVITY IN DISEASE (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 155-159, 1993) [J].
DINARELLO, CA .
IMMUNOLOGY TODAY, 1993, 14 (06) :260-264
[4]  
DINARELLO CA, 1991, BLOOD, V77, P1627
[5]  
DIPADOVA F, 1991, CLIN EXP IMMUNOL, V85, P137
[6]   INTERLEUKIN-1 RECEPTOR ANTAGONIST IS A MEMBER OF THE INTERLEUKIN-1 GENE FAMILY - EVOLUTION OF A CYTOKINE CONTROL MECHANISM [J].
EISENBERG, SP ;
BREWER, MT ;
VERDERBER, E ;
HEIMDAL, P ;
BRANDHUBER, BJ ;
THOMPSON, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5232-5236
[7]  
FAHERTY DA, 1992, J IMMUNOL, V148, P766
[8]  
FISCHER E, 1992, BLOOD, V79, P2196
[9]   PRODUCTION OF INTERLEUKIN-1-RECEPTOR ANTAGONIST DURING EXPERIMENTAL ENDOTOXEMIA [J].
GRANOWITZ, EV ;
SANTOS, AA ;
POUTSIAKA, DD ;
CANNON, JG ;
WILMORE, DW ;
WOLFF, SM ;
DINARELLO, CA .
LANCET, 1991, 338 (8780) :1423-1424
[10]  
GRANOWITZ EV, 1991, J BIOL CHEM, V266, P14147